MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

World Cancer Day aims to raise awareness for the prevention, detection, and treatment of all kinds of cancers, with ...